Study Comparing a New Painkiller to an Older One in Healthy People
Treatments studied
Part of Pain clinical trials.
This trial tests a new long-acting painkiller called HYR-PB21 to see how it compares to the standard drug bupivacaine. Healthy volunteers will receive one dose and be monitored for safety and how the drug moves through their body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 50 years old
- You have a body mass index (BMI) between 18 and 32 and weigh at least 50 kg (110 lbs)
- You do not smoke and have not used marijuana or other recreational drugs for at least 6 months
- You have no history of allergies to numbing medicines like lidocaine
- You are willing to avoid alcohol, caffeine, and certain medications during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called HRS-2129 for managing pain after abdominal surgery. It is for adults who will have moderate to severe pain after their operation, and aims to see if the drug can help control that pain safely.
This trial compares two pain relievers, hydromorphone and nalbuphine, given through a patient-controlled pump after cesarean section. It aims to find which provides better pain control with fewer side effects.
This trial tests a new tablet called HL-1186 for people with moderate to severe pain after certain surgeries. It aims to see if the drug is safe and works well for pain control.
This trial tests a new drug combination (DW-1021) against two common pain medications (Pelubi CR and Zytram CR) taken separately. Participation helps researchers understand how the drugs compare in healthy men.
This study tests a new medication called HSK55718 to help manage pain after orthopedic (bone and joint) surgery. Researchers want to see if it works better or as well as other pain treatments and is safe to use.
This trial tests if a new medicine, CBP-0276, can help reduce the amount of opioids needed for pain after major bone surgery. It may help manage pain with fewer side effects.
Hear when a new Postoperative Analgesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.